Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
Figure 2
Kaplan-Meier overall (a) and progression-free (b) survival curves for epithelial ovarian cancer patients with high and low RUNX2 expression. Epithelial ovarian cancer patients with high RUNX2 expression had significantly shorter overall () and progression-free () survival than those with low RUNX2 expression did.